Atlas Trials

Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00546910 · COMPLETED

Trial details

NCT number
NCT00546910
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2007-10-01
Primary completion
2009-05-01
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.